AI in Clinical Trials Market Expected to Surpass USD 7.6 Billion by 2030, Growing at a CAGR of 23.0% | IMR
 AI in Clinical Trials Market Overview The integration of Artificial Intelligence (AI) in clinical trials has revolutionized the pharmaceutical and healthcare industries by accelerating drug development and enhancing trial efficiency. AI technologies are transforming traditional processes, offering predictive analytics, real-time data analysis, and patient-centric solutions....
0 Σχόλια 0 Μοιράστηκε